Instil Bio (TIL) Long-Term Investments (2023 - 2025)
Instil Bio (TIL) posted quarterly Long-Term Investments of $3.4 million for Q3 2025, up 32.97% year-over-year from $2.6 million in Q3 2024, and down 70.94% quarter-over-quarter from $11.7 million in Q2 2025.
Instil Bio (TIL) Long-Term Investments (2023 - 2025) Analysis & Trends
Instil Bio's Long-Term Investments history runs 3 years deep, the most recent figure standing at $3.4 million for Q3 2025.
- In Q3 2025, Long-Term Investments rose 32.97% year-over-year to $3.4 million; the TTM figure through Sep 2025 stood at $3.4 million (up 32.97% YoY), while the FY2023 annual figure was $23.2 million, changed N/A from the prior year.
- Long-Term Investments for Q3 2025 stood at $3.4 million, down from $11.7 million in the prior quarter.
- The five-year high for Long-Term Investments was $23.2 million in Q4 2023, with the low at $2.6 million in Q3 2024.
- The 3-year median for Long-Term Investments is $7.2 million (2025), against an average of $8.5 million.
- Peak annual rise in Long-Term Investments reached 192.5% in 2025, while the deepest fall reached 6.64% in 2025.
- Instil Bio's Long-Term Investments stood at $23.2 million in 2023, then tumbled by 88.98% to $2.6 million in 2024, then jumped by 32.97% to $3.4 million in 2025.
- Business Quant data shows TIL's Long-Term Investments at $3.4 million in Q3 2025, $11.7 million in Q2 2025, and $7.2 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 1.77 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 22.17 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 372.10 Mn |
| 10 | Instil Bio | 51.68 Mn | 51.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3.40 Mn |
| Jun 30, 2025 | 11.70 Mn |
| Mar 31, 2025 | 7.19 Mn |
| Sep 30, 2024 | 2.56 Mn |
| Jun 30, 2024 | 4.00 Mn |
| Mar 31, 2024 | 7.70 Mn |
| Dec 31, 2023 | 23.20 Mn |